| Page 185 | Aplastic Anemia and MDS International Foundation

Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparinux

Author(s): 
Cheng KL, Brody J, Warshall CE, Sloand EM, Allen SL
Primary Author: 
Cheng KL
Journal Title: 
Leuk Res.
Original Publication Date: 
Apr 2010

No abstract available.

Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

Author(s): 
Santarone S, Bacigalupo A, Risitano AM, Tagliaferri E, Di Bartolomeo E, Iori AP, Rambaldi A, Angelucci E, Spagnoli A, Papineschi F, Tamiazzo S, Di Nicola M, Di Bartolomeo P.
Primary Author: 
Santarone S
Journal Title: 
Haematologica
Original Publication Date: 
Dec 2009

BACKGROUND:

Paroxysmal nocturnal hemoglobinuria is an acquired clonal disorder of the

Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab.

Author(s): 
Helley D, de Latour RP, Porcher R, Rodrigues CA, Galy-Fauroux I, Matheron J, Duval A, Schved JF, Fischer AM, Socié G; French Society of Hematology.
Primary Author: 
Helley D
Journal Title: 
Haematologica
Original Publication Date: 
Apr 2010

BACKGROUND:

Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry.

Author(s): 
Borowitz MJ, Craig FE, Digiuseppe JA, Illingworth AJ, Rosse W, Sutherland DR, Wittwer CT, Richards SJ; Clinical Cytometry Society
Primary Author: 
Borowitz MJ
Journal Title: 
Cytometry B Clin Cytom
Original Publication Date: 
Jul 2010

BACKGROUND:

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematopoietic stem cell disorder